Intracellular Hyaluronan Synthesis Impairs Hematopoiesis in Diabetes that can be Prevented by Heparin
Open Access
- 23 March 2023
- journal article
- research article
- Published by Scientific Archives
- Vol. 5 (1) , 1-6
Abstract
Hyperglycemia in diabetes induces impairment of hematopoiesis, an important consequence in bone marrow (BM) that contributes to chronic complicationsKeywords
This publication has 24 references indexed in Scilit:
- Progenitor Cell Dysfunctions Underlie Some Diabetic ComplicationsThe American Journal of Pathology, 2015
- Obesity-driven disruption of haematopoiesis and the bone marrow nicheNature Reviews Endocrinology, 2014
- Hyperglycemia Diverts Dividing Osteoblastic Precursor Cells to an Adipogenic Pathway and Induces Synthesis of a Hyaluronan Matrix That Is Adhesive for MonocytesJournal of Biological Chemistry, 2014
- The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAcMatrix Biology, 2014
- Heparin Prevents Intracellular Hyaluronan Synthesis and Autophagy Responses in Hyperglycemic Dividing Mesangial Cells and Activates Synthesis of an Extensive Extracellular Monocyte-adhesive Hyaluronan Matrix after Completing Cell DivisionJournal of Biological Chemistry, 2014
- CNS Inflammation and Bone Marrow Neuropathy in Type 1 DiabetesThe American Journal of Pathology, 2013
- Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1Proceedings of the National Academy of Sciences, 2012
- Bone inflammation and altered gene expression with type I diabetes early onsetJournal of Cellular Physiology, 2008
- Understanding the pathology and mechanisms of type I diabetic bone lossJournal of Cellular Biochemistry, 2007
- Heparin and heparan sulfate: structure and functionNatural Product Reports, 2002